Dr Amit Bhatt is a Consultant Medical and Molecular Oncologist at Apollo Hospitals, Pune, with extensive training in internal medicine, oncology, and molecular cancer care. He holds qualifications including MBBS, MD Medicine, DNB Medicine, ECMO, and a master's in molecular Oncology.
Dr Bhatt specializes in the diagnosis and treatment of a wide range of cancers, with a special interest in Medical Oncology and Precision Oncology. His approach focuses on personalized cancer treatment strategies, utilizing advanced molecular and targeted therapies to help optimize patient outcomes. He is experienced in managing complex oncological conditions and delivering evidence-based cancer care tailored to individual patient needs.
Practicing at Apollo Hospitals in Pune, Dr Bhatt works closely with multidisciplinary teams to provide comprehensive cancer management, from diagnosis and treatment planning to long-term follow-up care. He is committed to helping patients and their families understand their treatment options and make informed healthcare decisions. Dr Bhatt communicates fluently in English and Hindi, enabling effective interaction with patients from diverse backgrounds seeking expert oncology care in Pune.
Institution: Principal Investigator – Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharashtra
PRoFESS Study: I was the Investigator at Sevagram of this multi-centric international trial. A randomized control trial of Aspirin vs. Clopidogrel and Dipyridamole, and Telmisartan vs. Placebo to prevent second stroke. This trial is evaluating the efficacy of anti-platelets (aspirin vs. a combination of clopidogrel and dipyridamole) and ACE Inhibitor (Telmisartan) in stroke survivors to prevent second stroke in them.
2005 to 2007
Institution: Study Coordinator – Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharashtra
OASIS 6 Study: A randomized control trial of fondaparinaux vs. placebo in patients with ST elevation myocardial infarction, evaluated the role of a new anticoagulant (Fondaparinaux) in management of patients with acute myocardial infarction.
2010 Onwards
Institution: Study Coordinator – Christian Medical College, Vellore, Tamil Nadu
ASCOLT Study - - Aspirin for Dukes C and HighRisk Dukes B Colorectal Cancers - An International, Multi-centre, Double Blind, Randomized Placebo Controlled Phase III Trial
CanterRisk Study - - AA prospective, noninterventional, cohort survey on VTE risk in patients receiving new chemotherapy for cancer
SHINE Study - - - A Randomized, Open Label Phase IIa Study to assess the Efficacy and Safety of AZD4547 Monotherapy versus Paclitaxel in patients with Advanced Gastric or Gastro-esophageal Junction Cancer with FGFR2 Polysomy or Gene Amplification
EPO-ANE-3010 - - - A Randomized, Open-Label, Multicenter, Phase 3 Study of Epoetin Alfa plus Standard Supportive Care versus Standard Supportive Care in Anemic Patients with Metastatic Breast Cancer Receiving Standard Chemotherapy
TNBC Study - - - A Multi centre, pilot phase II trial assessing the efficacy and safety of Bevacizumab + Gemcitabine + Carboplatin as first line treatment for patients diagnosed with Triple Negative Metastatic Breast Cancer
INDOX Breast Study - - - Risk Factors for Breast Cancer in India: INDOX Case-Control Study
INDOX Colorectal Study - - - - Risk Factors for Colorectal Cancer in India: INDOX Case-Control Study
ADYAR-SIOG Study - - - - Phase III, Randomized controlled trial of perioperative versus postoperative chemotherapy in resectable carcinoma stomach
2013 onwards
Institution: Sanjeevan Hospital, Pune
Protocol RI-01-002 A Randomized, Multi-center, Double-blind, Parallel Group Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Two Anti-CD20 Monoclonal Antibodies in Combination with CHOP in Patients with CD20-Positive Diffuse Large B-cell Lymphoma
A Multicenter, randomized, open label, two treatments, two period, two sequence, multipledose, cross-over, bioequivalence study of Everolimus 10 mg tablet once daily manufactured by Par Pharmaceutical with Everolimus 10 mg tablet manufactured by: Novartis Pharma in Advanced Renal Cell Carcinoma patients under fasting condition
An open label, randomized, balanced, twotreatment, two-period, two-sequence, singledose, crossover, oral bioequivalence study of 60 mg/m2 of Vinorelbine soft capsule from Lotus Pharmaceutical Co., Ltd., Taiwan compared with that of 60 mg/m2 of NAVELBINE® soft capsule marketed by PIERRE FABRE Limited, Winchester Hampshire S023 7DR, United Kingdom, in adult, patients with advanced breast cancer under fed condition
Memberships
Member, European Society of Medical Oncology
Member, American Society of Clinical Oncology
Member, Associations of Physicians of India
Member, Indian Society of Oncology
Member, India Academy of Geriatrics
Member, Indian Society of Medical and Pediatric Oncology
Awards & Achievements
I Have Co-Authored Chapters in Textbooks of Repute:
1)Lung Cancer 2012, API: Chapter on Epidermal Growth Factor Receptor in Lung Cancer.
2)ICU Manual, Paras Publications: Chapters: Acute Respiratory Failure, Mechanical Ventilation.
3)Breast Cancer Update 2014: Bone Health in Breast Cancer.
4)Current Status and Role of Human Papillomavirus in Head and Neck Cancer in India: ICON Conference 2016.
I Am Trained in Critical Care by Society of Critical Care Medicine, California Under the Fundamental Critical Care Support Course.
I Have Undergone Specialized Training in Neurology Under Dr. JMK Murthy in the Department of Neurology, Care Hospital, Hyderabad.
I Have Co-Authored Two Textbooks and 1 CD
1)Care of Elderly in General Practice, a Handbook in Geriatrics Care Published by Paras Medical Publishers, Hyderabad. [Review Published in IAG Journal].
2)Textbook of Family Medicine, a Curriculum Textbook for DNB Family Medicine Published by Paras Medical Publishers, Hyderabad. [Review Published in Journal of PG Med Education of DNB].
3)CD ROM - Medical Presentations 2007, a Medical Update in 150 PowerPoint Topics.
Post Doctoral Fellowship in Medical Oncology
Research & Publications
01
AD Bhatt, M Joshi, AP Jain. Drug Update-Sulbactam Sodium; Indian Journal of Clinical Practice, May 2006; Vol16, No 12.
02
M Joshi, AD Bhatt, AP Jain. Drug Update-Imipenem and Cilastatin; Indian Journal of Clinical Practice, May 2006; Vol16, No 12.
03
AD Bhatt, M Joshi. Stem Cell Therapy; JMGIMS, Vol 11, No ii, Sept 06.
04
AD Bhatt, J Jain, OP Gupta. The Giant Left Atrium; JMGIMS, Sept 06; Vol 11, No ii.
05
AD Bhatt, S Babhulkar, J Jain, OP Gupta. Pictorial CME- Glioblastoma Multiforme; JMGIMS, Sept 06; Vol 11, No ii; 58-59.
06
R Joshi, AD Bhatt, AP Jain, JM Colford. Fever and Altered Sensorium in Adults Presenting to the Emergency Medicine Department of a Rural Hospital in Central India: A Clinicodemographic Profile; Journal of General Medicine, Vol 18. No.3, Sept 06; 14-18.
07
AP Jain, B Chauhan, AD Bhatt. Sociodemographic and Clinical Profile of Headache – A Rural Based Hospital Study; Journal of Indian Academy of Clinical Medicine [JIACM], Vol 8, Number 1 Jan-Mar 2007, 26-28.
08
AD Bhatt. Medical Marvels; JMGIMS, Vol 12, Number (i) March 2007, 68-71.
09
AD Bhatt, OP Gupta. Drug Review- The Seventh Factor [Recombinant Factor VIIa]; JMGIMS Vol 12, Number (i) March 2007, 53-55.
10
AD Bhatt, AP Jain. The History of a Dreaded Killer-ki Denga Pepo; The Journal of General Medicine, Jan-Mar 2007, Vol 19 No 1; 13-15.
11
AD Bhatt, J Jain, OP Gupta; Primary Ciliary Dyskinesia [Kartagener’s Syndrome], The Indian Practioner, March 2007 Vol 61: No.3:32-37.
12
AP Jain, P B Behere, H K Sidhwa, N Chauhan, P Ghate, AD Bhatt. Study of Clinico-Aetiological Profile and Role of Psychiatric Comorbidity in Functional Gastrointestinal Disorders IJCP, May 2007: Vol17, No12;35-41.
13
N Gangane. Churg Strauss Disease – An Unusual Presentation; Asian Journal of Clinical Cardiology, Sept 07, Vol 10:5; 43-46.
14
AD Bhatt, MN Joshi. Cardiovascular Cartography. JMGIMS Vol 12, Number (ii) September 2007, 59-62.
15
AD Bhatt, AN Joshi. Drug Review- Pregabalin. JMGIMS, Vol 12, Number (ii) September 2007, 63-64.
16
AD Bhatt. Type1.5 Diabetes Mellitus JMGIMS, Vol 13, Number (ii) September 2007, 25-29.
17
AD Bhatt, AN Joshi. Diabetes – Back to the Future. JMGIMS, Vol 13, Number (ii) September 2007, 32-34. e Reports.
18
Jain AP, Patil N, AD Bhatt. The Study of Prevalence of Sleep Apnea in Chronic Obstructive Airway Disease Patients. The Indian Practioner, April 2008; Vol 61: No.4.
19
Aspirin and Extended-Release Dipyridamole Versus Clopidogrel for Recurrent Stroke-Profess Study Group. N Engl J Med. 2008 Sep; 359(12):1238-51. PMID: 18753638.
20
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events-Profess Study Group. N Engl J Med. 2008 Sep; 359(12):1225-37. PMID: 18753639.
21
Effects of Aspirin Plus Extended-Release Dipyridamole Versus Clopidogrel and Telmisartan on Disability and Cognitive Function After Recurrent Stroke in Patients with Ischemic Stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (Profess) Trial: A Double-Blind, Active and Placebo-Controlled Study. Lancet Neurol. 2008 Oct; 7(10):875-84. PMID: 18757238.
22
AD Bhatt, J Ingole, S Kumar, A Jain. Bilateral Proptosis: Unusual Presentation of Cortical Sinus Thrombosis. The Internet Journal of Internal Medicine. ISSN: 1528-8382 Volume 8 Number 1.
23
AD Bhatt, J Jain, OP Gupta, Joshi AN, Jain AP, Bhatt AD, Kumar S. A Case of Sporadic Periodic Hypokalemic Paralysis with Atypical Features: Recurrent Differential Right Brachial Weakness and Cognitive Dysfunction. Neurol India 2009; 57:501 PMID: 19770562.
24
AD Bhatt, AN Joshi, AP Jain. Anaphylactic Shock: A Rare Presentation of Phenytoin Drug Reaction. IJCP, Vol. 21, No. (1), June 2010.
25
AD Bhatt, AN Joshi. Tuberculosis Treatment- Guidelines Review. JMGIMS, March 2010.
26
AD Bhatt, Joshi AN, J Jain, OP Gupta. Reactive Perforating Collagenosis Masquerading as Rheumatoid Arthritis. Singapore Med J 2010; 51(8): 676.
27
AN Joshi, AD Bhatt, AP Jain. Hypokalaemic Periodic Paralysis – Faces Behind the Mask: Profile in Rural Central India. JIACM 2010; 11(2): 116-20.
28
R Pai, AG Nehru, AD Bhatt et al. ST49-Activating EGFR Mutations Among Patients with Non-Small Cell Lung Cancer from India. Annual Meeting Abstracts- J Mol Diagn. 2011 Nov;13(6):707-795.
29
Bhatt AD, Pai R, Rebekah G, Nehru GA, Dhananjayan S, Samuel A, Singh A, Joel A, Korula A, Chacko RT. Clinicopathologic Features of Non-Small Cell Lung Cancer in India and Correlation with Epidermal Growth Factor Receptor Mutational Status. Indian J Cancer. 2013 Apr-Jun;50(2):94-101.
30
Joel A, Bhatt AD, Samuel A, Chacko RT. Cutaneous Metastasis from Testicular Germ Cell Tumour. Indian J Urol. 2014 Jan;30(1):99-101.
31
Bhatt AD, Joel A, Chacko R. Lesser-Known Evil of a Commonly Used Devil-Bleomycin Induced Flagellate Dermatitis. Indian Dermatol Online J 2014; 5:517.
32
Joel A, Samuel A, Bhatt AD, Chandramohan A1, Chacko RT. Carcinoma of the Gallbladder Presenting with Multiple Osseous and Inguinal Lymph Node Metastases. Indian Journal of Cancer. April-June 2015: Volume 52; Issue 2.
33
AD Bhatt, D Patil, I Patwal, DB Akolkar, DA Joshi, P.P. Patil, RR Dasare, TD Bhangale, YR Jha, AA Ranade. Liquid Biopsy in Periampullary Carcinoma. International Journal of Molecular & ImmunoOncology: Vol 1, No 1 (2016);45-47.
34
A.D. Bhatt, A.A. Ranade. A Retrospective Observational Study of Efficacy and Safety of Genexol-PM, a Novel Cremophor-Free, Polymeric Micelle Formulation of Paclitaxel, in Patients with Solid Tumours. Annals of Oncology, Volume 27, Issue suppl_9, 1 December 2016.
35
Application of Next Generation Sequencing (NGS) in Diagnosis and Prognosis of Hematological Malignancies. Kelkar, V Ramanan, S Ranade, T Wathare-Ragte, N Gogate, P Gangodkar, K Patil, M Agarwal, K Khatod, AD Bhatt, N Phadke. Personalized Hematology: Indian Journal of Hematology and Blood Transfusion, November 2017, Issue 1 Supplement, Pages 1-126 [Abstract].
36
Murthy V, Calcuttawala A, Chadha K, d’Cruz A, Krishnamurthy A, Mallick I, AD Bhatt, et al. Human Papillomavirus in Head and Neck Cancer in India: Current Status and Consensus Recommendations. South Asian J Cancer 2017; 6:93-8.
37
Lung Cancer: Beyond EGFR and ALK Dichotomy. C.T. Satheesh, AD Bhatt, M. Singhal, R. Aarthi, K. Shubham, G. Madhura, V. Maka, R. Naik, S. Iyer, G. Shafi. Journal of Thoracic Oncology Vol. 13 No. 4S: S1-S139.
38
S Iyer, R Prajapati, AD Bhatt, Et Al. The Future of Lung Cancer Therapy: Striding Beyond Conventional EGFR and ALK Treatments. Molecular and Clinical Oncology 10: 469-475, 2019.
39
Mehta, P, Bhatt AD et al. Landscape of Tumor Mutational Burden in Indian NSCLC Patients. Journal of Thoracic Oncology, Volume 14, Issue 10, S462 - S463.
40
Ranade AA, Bhatt A, Darshana P, Indu P, Akolkar DB, Joshi DA, Patil PP, Dasare RR, Bhangale TD, Jha YR. Liquid Biopsy in Periampullary Carcinoma. Int. J. Mol. (2016).
41
Ranade A, Patil D, Bhatt A, Dhasare R, Datta V, Datar R, Akolkar D. Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC. (2019).
42
Crook T, Akolkar D, Patil D, Bhatt A, Ranade A, Datta V, Schuster S, Srinivasan A, Datar R. Encyclopedic Tumor Analysis for Organ Agnostic Treatment with Axitinib in Combination Regimens for Advanced Cancers. (2019).
43
Thirumalairaj R, Parikh P.M, Agarwal A, Bhatt AD, et al. South Asian Declaration—Consensus Guidelines for COVID-19 Vaccination in Cancer Patients. South Asian J Cancer 2021;10(1):3–8.
44
Parikh P, Kapoor A, Joshi K, Bansal I, Krishna V, Sahoo TP, Bhatt AD et al. Advanced Lung Cancer and Molecular Testing in the Middle of Coronavirus Disease 2019 Second Wave in the South Asian Association for Regional Cooperation Region. Int J Mol Immunol Oncol 2021;6(2):61-5.
45
Murthy V, Calcuttawala A, Chadha K, d’Cruz A, Krishnamurthy A, Mallick I, et al. Human Papillomavirus in Head and Neck Cancer in India: Current Status and Consensus Recommendations. South Asian Cancer 2017; 6:93-8.
46
Akolkar DB, Crook T, Patil D, Ranade A, Bhatt A, Limaye S, Datta V, Schuster S, Sims C, Srivastava N, Fulmali P. Multi-Analyte Interrogation-Based Treatment of Advanced Refractory Cancers. (2020).
47
Limaye S, Patil D, Akolkar DB, Crook T, Ranade A, Bhatt A, Datta V, Schuster S, Sims C, Srivastava N, Fulmali P. Multi-Analyte Liquid Biopsies-Based Treatment in Advanced Refractory Cancers. (2020).
48
Ranade A, Bhatt A, Page R, Limaye S, Crook T, Akolkar D, Patil D. Hallmark Circulating Tumor-Associated Cell Clusters Signify 230 Times Higher One-Year Cancer Risk. Cancer Prevention Research. (2021).
49
Crook T, Gaya A, Page R, Limaye S, Ranade A, Bhatt A, Patil S, Kumar P, Patil D, Akolkar D. Clinical Utility of Circulating Tumor-Associated Cells to Predict and Monitor Chemo-Response in Solid Tumors. (2021).
50
Gaya A, Crook T, Plowman N, Ranade A, Limaye S, Bhatt A, Page R, Patil R, Fulmali P, Datta V, Kumar P, Patil D, Akolkar D. Evaluation of Circulating Tumor Cell Clusters for Pan-Cancer Noninvasive Diagnostic Triaging. (2021).
51
Crook T, Patil D, Gaya A, Plowman N, Limaye S, Ranade A, Bhatt A, Page R, Akolkar D. Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers. (2021).
52
Crook T, Patil D, Nagarkar R, Gaya A, Plowman N, Limaye S, Srivastava N, Akolkar D, Ranade A, Bhatt A, Datta V, Bose C, Apurwa S, Patil S, Kumar P, Srinivasan A, Datar R. Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers. (2021).
53
Crook T, Limaye S, Ranade A, Bhatt AD, Apurwa S, Patil D, Datar R, Kurzrock R. Outcomes of Personalized Therapy Guided by Exacta Encyclopedic Tumor Analysis for Women with Broadly Refractory Advanced Breast Cancer. (2024).
54
Choudhary RK, Koppaka D, Vaid AK, Kulkarni SS, Bose C, Morzaria DD, Apurwa S, Vijayan P, Bhatt AD, Ranade A, Page R. Spectrum of HER2 Alterations in NSCLC: Comparative Analysis of Tissue and Liquid Biopsies in Lung Cancer. (2024).
55
Parikh, P., Babu, G., Singh, R. Bhatt AD et al. Consensus Guidelines for the Management of HR-Positive HER2/neu Negative Early Breast Cancer in India, SAARC Region and Other LMIC by DELPHI Survey Method. BMC Cancer 23, 714 (2023).
56
Anant Ramaswamy, Kripa Bajaj, Bhatt AD et al. Ramucirumab in Indian Patients with Advanced Gastric Cancer—Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit? September 2021. South Asian Journal of Cancer 11(03).
57
Parikh PM, Biswas G, Dhamne NA, Bhatt AD et al. Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC). South Asian J Cancer 2024.
Best Hospital Near me Chennai